4dmoleculartherapeutics.com valid
Automatically discovered from public files. Ownership management is optional. Inclusion does not imply endorsement or publisher participation.
Manage this listing — optional · Visit publisher ↗
What verification unlocks
See how your site is discovered—and control what agents see.
- Control what agents see
Edit your listing description, tags, public contact details and additional llms.txt paths. Publish your terms for automated access, attribution and pricing.
- Make your profile eligible for search
A valid, listed, unblocked, verified profile can appear in our publisher sitemap and become eligible for search-engine visibility. Search engines decide what to index and rank.
- Appear in our llms-full.txt
Eligible verified publishers are listed by name, with their file links and summaries, in the service overview agents can read.
Free. No account registration, backlink or payment required. Public discovery remains available without verification.
Let your coding agent verify it
If your coding agent is authorized to manage this website, paste these instructions into it.
Claim my listing on Agent Web Map for 4dmoleculartherapeutics.com:
1. POST https://agentwebmap.com/v1/sites/4dmoleculartherapeutics.com/claims and keep claim_id and claim_secret private.
2. Publish the proof: add the line "AgentWebMap ownership: <token>" (token from step 1) to https://4dmoleculartherapeutics.com/llms.txt, or use the DNS, meta-tag or well-known method the response describes.
3. POST https://agentwebmap.com/v1/sites/4dmoleculartherapeutics.com/verify with {"claim_id": "...", "claim_secret": "..."}.
4. Save the api_key from the answer; it manages the listing (PATCH https://agentwebmap.com/v1/sites/4dmoleculartherapeutics.com).
MCP equivalent: tools begin_ownership_claim, then verify_domain, at https://agentwebmap.com/mcp. Docs: https://agentwebmap.com/docs#verifyCorrections or removal requests: contact the directory. Ownership management is optional.
4DMT
Generated by All in One SEO v5.0.2.1, this is an llms.txt file, used by LLMs to index the site.
- Authority
- 48 reach 7 · trust 5 · quality 21 · freshness 15
- Tier
- listed
- llms.txt
- https://4dmoleculartherapeutics.com/llms.txt
- Sections
- 6
- Links
- 175
- Size
- 34008 bytes
- Popularity rank
- #472681
- Categories
- Marketing
- For agents
- Documentation: developer or product docs worth reading, nothing to call
- First seen
- 2026-10-19T10:43:33.883Z
- Last checked
- 2026-10-21T04:13:36.475Z
- Badge
Their llms.txt
The beginning of the file, from our validated copy saved 2026-10-21T04:13:32.281Z. Cached copy · Source on 4dmoleculartherapeutics.com
# 4DMT
> Generated by All in One SEO v5.0.2.1, this is an llms.txt file, used by LLMs to index the site.
Powering The Future Of Genetic Medicines
## Sitemaps
- [XML Sitemap](https://4dmoleculartherapeutics.com/sitemap.xml): Contains all public & indexable URLs for this website.
## Posts
- [A Strategic Shift for Gene Therapies: Manufacturing and Market Size Take Centre Stage](https://urldefense.com/v3/__https://www.pharmaceutical-technology.com/features/a-strategic-shift-for-gene-therapies-manufacturing-and-market-size-take-centre-stage/__;!!N96JrnIq8IfO5w!jgMg2cEjX6bziZ4JJJL6Qyth3pphIm00rAqLrzKMdTD-qS7M6wIS15gUfEd1DErRG4Tc-GEr6oFXd0n6EVF2$#new_tab)
- [4DMT's 2-year PRISM Data Show Durable Treatment Burden Reduction with 4D-150 in Wet AMD](https://www.ophthalmologytimes.com/view/4dmt-s-2-year-prism-data-show-durable-treatment-burden-reduction-with-4d-150-in-wet-amd#new_tab)
- [4DMT Targets Global Retina Market with Long-lasting Genetic Treatment](https://www.rbccm.com/en/insights/2026/06/4dmt-targets-global-retina-market-with-long-lasting-genetic-treatment#new_tab)
- [4D-150 Gene Therapy Reduces Treatment Burden in Wet AMD](https://www.healio.com/news/ophthalmology/20260811/4d150-gene-therapy-reduces-treatment-burden-in-wet-amd#new_tab)
- [ASRS 2026: 4D-150 Gene Therapy Shows Sustained Treatment-burden Reduction in Wet AMD at 2 years](https://www.ophthalmologytimes.com/view/asrs-2026-4d-150-gene-therapy-shows-sustained-treatment-burden-reduction-in-wet-amd-at-2-years#new_tab)
- [Dramatic Results Seen With Gene Therapy for Age-Related Macular Degeneration](https://www.medpagetoday.com/meetingcoverage/asrs/122265#new_tab)
- [4DMT Completes Enrollment in 4FRONT-2, Global Phase 3 Trial of 4D-150 in Wet AMD](https://www.ophthalmologytimes.com/view/4dmt-completes-enrollment-in-4front-2-global-phase-3-trial-of-4d-150-in-wet-amd#new_tab)
- [4DMT Completes Enrollment in Second Phase 3 Trial of 4D-150 for Wet AMD](https://eyewire.news/news/4dmt-completes-enrollment-in-second-phase-3-trial-of-4d-150-for-wet-amd?c4src=article:infinite-scroll#new_tab)
- [The Onyx Life Sciences Report: Companies we're watching in 2026](https://online.fliphtml5.com/vfvls/Onyx_Life_Sciences_Fortune/#p=2#new_tab)
- [Scrip Asks... What Does 2026 Hold For Biopharma? Part 4: R&D Innovation](https://insights.citeline.com/scrip/scrip-asks/scrip-asks-what-does-2026-hold-for-biopharma-part-4-rd-innovation-NDREFKFVB5DZPAQLA5CIZHE7OI/#new_tab)
- [4DMT Completes Enrollment in Gene Therapy Trial for Wet AMD](https://www.retinalphysician.com/news/2026/4dmt-completes-enrollment-in-wet-amd-trial/#new_tab)
- [4DMT Completes Enrollment for Phase 3 Trial of 4D-150 for Wet AMD](https://eyewire.news/news/4dmt-completes-enrollment-for-4d-150-clinical-trial?c4src=article:infinite-scroll#new_tab)
- [The gene therapy shift: A closer look at the science powering next-generation retinal treatments](https://www.modernretina.com/view/the-gene-therapy-shift-a-closer-look-at-the-science-powering-next-ge
…Related sites
Other listed sites in Marketing. See the whole category →
| Domain | Title | Category | Country | Authority | llms.txt | llms-full.txt |
|---|---|---|---|---|---|---|
| hubspot.com | HubSpot | documentation Marketing | 72 | ✓ | ||
| beehiiv.com | beehiiv | interface Marketing | 70 | ✓ | ✓ | |
| sendbird.com | Sendbird | documentation AI and machine learning Developer tools +1 | US | 70 | ✓ | ✓ |
| braze.com | Braze | documentation Marketing | 69 | ✓ | ||
| gumgum.com | GumGum | documentation Marketing | 69 | ✓ | ||
| optimizely.com | Optimizely | documentation Marketing AI agents and MCP | US | 69 | ✓ | |
| semrush.com | Semrush | documentation Marketing | US | 69 | ✓ | |
| siteground.com | SiteGround | documentation AI and machine learning Design +2 | US | 69 | ✓ | ✓ |
Help agents understand your site
Optionally manage your description, publish terms for agents, review file health, measured discovery requests, publisher clicks and score history. Confirm domain control in your browser using a fresh token in your llms.txt, DNS, meta tag or well-known file. No backlink is required.
Manage this listing → · Agent and API instructions
Machine-readable: GET /v1/resolve?q=4dmoleculartherapeutics.com · GET /v1/domain/4dmoleculartherapeutics.com · this page as Accept: application/json or text/markdown · MCP lookup_domain